MGQLX
Price
$11.67
Change
-$0.11 (-0.93%)
Updated
Jun 22 closing price
Net Assets
21.62M
RWIBX
Price
$80.66
Change
-$0.06 (-0.07%)
Updated
Jun 22 closing price
Net Assets
159.53B
Interact to see
Advertisement

MGQLX vs RWIBX

MGQLX vs RWIBX Comparison Chart in %
View a ticker or compare two or three
VS
MGQLX vs. RWIBX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGQLX is a Hold and RWIBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 160B vs. MGQLX (21.6M). RWIBX pays higher dividends than MGQLX: RWIBX (0.74) vs MGQLX (0.00). MGQLX was incepted earlier than RWIBX: MGQLX (13 years) vs RWIBX (24 years). MGQLX (2.45) is less costly to investors than RWIBX (1.51). MGQLX is a more actively managed with annual turnover of: 49.00 vs. RWIBX (44.00). MGQLX has a lower initial minimum investment than RWIBX: MGQLX (0) vs RWIBX (250). RWIBX annual gain was more profitable for investors over the last year : 17.83 vs. MGQLX (-29.38). RWIBX return over 5 years is better than : 27.84 vs. MGQLX (-32.61).
MGQLXRWIBXMGQLX / RWIBX
Total Expense Ratio1.651.51109%
Annual Report Gross Expense Ratio2.451.51162%
Fund Existence13 years24 years-
Gain YTD-4.46113.017-34%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets21.6M160B0%
Annual Yield % from dividends0.000.74-
Returns for 1 year-29.3817.83-165%
Returns for 3 years-28.6946.73-61%
Returns for 5 years-32.6127.84-117%
Returns for 10 years3.8898.114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIPSX44.07N/A
N/A
ProFunds Biotechnology UltraSector Svc
TSVRX22.11N/A
N/A
PGIM Quant Solutions Small-Cap Val R
ACAYX66.15N/A
N/A
Alger Capital Appreciation Instl Y
FIJCX89.83N/A
N/A
Fidelity Advisor Consumer Staples Z
DFIEX22.01-0.42
-1.87%
DFA International Core Equity 2 I